Evaluation of methods for large scale preparation of antibody ligand conjugates

Nuclear Medicine and Biology

Volumn 26, Issue 3, 1999, Pages 339-342

  Wu, Chuanchu ^a   Gansow, Otto A ^a   Brechbiel, Martin W ^a,b  

^a NATIONAL CANCER INSTITUTE   (United States)

^b REL TEK   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIBODY CONJUGATE; LIGAND; MONOCLONAL ANTIBODY;

ARTICLE; CHELATION; CONJUGATION; DIALYSIS; DRUG PURIFICATION; DRUG SYNTHESIS; FILTRATION; HUMAN; LIQUID SCINTILLATION COUNTING; RADIOCHEMISTRY; TECHNIQUE;

ANTIBODIES, MONOCLONAL; BUFFERS; CARBON RADIOISOTOPES; CHELATING AGENTS; FILTRATION; HUMANS; IMMUNOCONJUGATES; IMMUNOGLOBULIN G; PENTETIC ACID; RADIOPHARMACEUTICALS;

EID: 0033119077     PISSN: 09698051     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0969-8051(98)00112-7     Document Type: Article

References (17)

1. Assony S. J. (1961) The chemistry of isothiocyanates. In: Organic Chemistry of Sulfur Compounds (Edited by Kharasch N.), Chapter 28. pp. 326-338. Pergamon Press, Oxford, UK.
2. 90Y radioimmunotherapy. Bioconjugate Chem. 2:1991;187-194.
3. Carrasquillo J.A., Reynolds J.C., Bunn P.A., Foon K.A., Shuke N., Schroff R.W., Mulshine J.L., Perentesis P., Szymendera J., Horowitz M., Larson S.M. Pharmacokinetics of In-111 T101 (anti-CD5) monoclonal antibody in patients with cutaneous T-cell lymphoma. Antibody Immunoconj. Radiopharm. 6:1995;111-126.
4. Co M.S., Avdalovic N.M., Caron P.C., Avdalovic M.V., Scheinberg D.A., Queen C. Chimeric and humanized antibodies with specificity for CD33 antigen. J. Immunol. 148:1992;1149-1154.
5. Fritzberg A.R., Berninger R.W., Hadley S.W., Wester D.W. Approaches to radiolabeling of antibodies for diagnosis and therapy of cancer. Pharm. Res. 5:1988;325.
6. Gansow O. A. and Wu C. (1995) Advanced methods for radiolabeling monoclonal antibodies with therapeutic radionuclides. In Cancer Therapy with Radiolabeled Antibodies (Edited by Goldenberg D. M.), Chapter 6, pp. 63-76. CRC Press, Inc., Boca Raton, FL.
7. Knox S.J., Goris M.L., Trisler K., Negrin R., Davis T., Liles T.-M., Grillo-Lopez A., Chinn P., Varns C., Ning S.-C., Fowler S., Deb N., Becker M., Marquez C., Levy R. Yttrium-90-labeled anti-CD20 monoclonal antibody therapy of recurrent B-cell lymphoma. Clin. Cancer Res. 2:1996;457.
8. Liu Y., Wu C. Radiolabeling of monoclonal antibodies with metal chelates. Pure Appl. Chem. 63:1991;427-463.
9. McCall M.J., Diril H., Meares C.F. Simplified method for conjugating macrocyclic bifunctional chelating agents to antibodies via 2-iminothiolane. Bioconjugate Chem. 17:1990;202-209.
10. Mirzadeh S., Brechbiel M.W., Atcher R., Gansow O.A. Radiometal labeling of immunoproteins Covalent linkage of 2-(4-isothiocyanatobenzyl)diethylenetriamine-pentaacetic acid ligand to immunoglobulin . Bioconjugate Chem. 1:1990;59-65.
11. Nikula T.K., Curcio M.J., Brechbiel M.W., Gansow O.A., Finn R.D., Scheinberg D.A. A rapid, single vessel method for preparation of clinical grade ligand conjugated monoclonal antibodies. Nucl. Med. Biol. 22:1995;387-390.
12. Parker D. Tumour targeting with radiolabelled macrocycle-antibody conjugates. Chem. Soc. Rev. 91:1990;217-291.
13. Pastan I., Lovelace E.T., Gallo M.G., Rutherford A.V., Magnani J.L., Willingham M.C. Characterizations of monoclonal antibodies B1 and B3 that react with mucinous adenocarcinomas. Cancer Res. 51:1991;3781-3787.
14. Pippin C.G., Parker T.A., McMurry T.J., Brechbiel M.W. Spectrophotometric method for the determination of a bifunctional DTPA ligand in DTPA-monoclonal antibody conjugates. Bioconjugate Chem. 3:1992;342-345.
15. Somayaji V.V., Naicker S.S., Sykes T.R., Guay V., Noujaim A.A. Preparation and protein conjugation of a divinyl sulphone derivatized bifunctional chelating agent. Cancer Biother. Radiopharm. 11:1996;405-414.
16. Somayaji V.V., Sykes T.R., Naicker S.S., Noujaim A.A. Optimization of protein conjugation using and aldehyde derivatized bifunctional chelating agent. Appl. Radiat. Isot. 47:1996;71-77.
17. Waldmann T.A., White J.D., Carrasquillo J.A., Reynolds J.C., Paik C.H., Gansow O.A., Brechbiel M.W., Jaffe E.S., Fleisher T.A., Goldman C.K., Top L.E., Bamford R., Zaknoen S., Roessler S., Kasten-Sportes C., Englang R., Litou H., Johnson J.A., Jackson-White T., Manns A., Hanchard B., Junghans R.P., Nelson D.L. Radioimmunotherapy of IL-2Rα-expressing adult T-cell leukemia with yttrium-90 labeled anti-Tac. Blood. 86:1995;4063-4075.